Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy

Journal of Clinical Oncology

Volumn 17, Issue 4, 1999, Pages 1155-1163

  Shipley, W U ^a  

^a American Society for Therapeutic Radiology and Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MALE; MICROSCOPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032906392     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.4.1155     Document Type: Article

References (17)

1. American Society of Therapeutic Radiology and Oncology Consensus Statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
2. Crook JM, Perry GA, Robertson S, et al: Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patients. Urology 45:624-632, 1995
3. Crook JM, Bahadur YA, Robertson SJ, et al: Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 79:81-89, 1997
4. Zelefsky MJ, Leibel SA, Gaudin PB, et al: Dose escalation with three-dimensional conformal radiation therapy effects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491-500, 1998
5. Forman JD, Duclos M, Shamsa F, et al: Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: Results of a dose escalation study. Int J Radiat Oncol Biol Phys 34:655-662, 1996
6. Grignon DJ, Christian S, Sarkar F, et al: Histologic and biologic effects of combined radiation therapy and maximal androgen blockade on prostate cancer. J Mol Urol (in press)
7. Nath R, Andersen L, Luxton G, et al: Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 22:209-234, 1995
8. Prestidge B, Hoak D, Grimm P, et al: Post treatment biopsy results following interstitial brachytherapy in early stage prostate cancer. Int J Radiat Oncol Biol 37:31-39, 1997
9. Grimm P, Blasko J, Ragde H, et al: Transperineal ultrasound guided I-125/Pd 103 brachytherapy in the management of localized prostate cancer: Update of the clinical experience at seven years. Proc Am Soc Ther Radiol Oncol 39:218, 1998 (suppl 2) (abstr 1008)
10. Morris MM, Dallow KC, Zietman AL, et al: Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 38:731-736, 1997
11. Connolly JA, Shinoharra K, Presti JC Jr, et al: Local recurrence after radical prostatectomy: Characteristics in size, location, and relationship to prostate specific antigen and surgical margins. Urology 47:225-231, 1996
12. Hudson MA, Catalona WJ: Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol 143:1174-1177, 1990
13. McCarthy JF, Catalona WJ, Hudson MA: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early versus delayed treatment. J Urol 151:1575-1578, 1994
14. Schild SE, Wong WW, Grado GL, et al: The use of radiotherapy for patients with isolated elevation of serum PSA levels following radical prostatectomy. Mayo Clin Proc 69:613-619, 1994
15. Schild SE, Buskirk SJ, Wong WW, et al: The use of radiotherapy for patients with isolated elevation of serum PSA levels following radical prostatectomy. J Urol 156:1725-1729, 1996
16. Forman JD, Shamsa F, Duclos M, et al: Predicting the need for adjuvant systemic therapy in patients receiving post-prostatectomy irradiation. Urology 47:382-386, 1996
17. Forman JD, Velasco J: Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology 12:33-39, 1998